Navigation Links
Physician's Role Diminished in Hospice Care by CMS Directive

ALEXANDRIA, Va., Oct. 31, 2013 /PRNewswire-USNewswire/ -- Today, the Centers for Medicare and Medicaid Services released a directive to Part D plan sponsors called "Clarification on Recovery of Part D Payment for Pain Medications for Beneficiaries Enrolled in Hospice".  What does this mean? In cases where the patient was enrolled in hospice and Part D, and the prescription drugs were paid for by Part D, CMS is directing plans to take back funds from hospices for patients' pain control medicines in 2011 and 2012.  For this payment recovery effort, CMS presumes that ALL pain medications "were used for the palliation and management of terminal illness and/or related conditions."  It is the National Hospice & Palliative Care Organization's position that this is not true.


Although the vast majority of pain medications prescribed to hospice patients are related to the terminal condition, it is simply false to presume that all are.  It is a dangerous precedent to presuppose that all analgesics ARE related to the terminal illness, without the voice of the hospice physician, who has patient-specific knowledge, and who is responsible for deciding whether a drug is related to the terminal illness or not.

"We are outraged that CMS would disregard the law and their own regulations to de-emphasize the role of the hospice physician in determining what care is required as part of the patient's terminal condition," said J. Donald Schumacher, NHPCO president and CEO.  "Thirty years of hospice statute and regulations  clearly  contradicts any attempt to recoup payments for any portion of the patient's plan of care without first determining if the care, in this case pain medication, was deemed related to the terminal condition by a physician."

In recent weeks, NHPCO has been working with CMS to try and sort out previous memoranda to Part D sponsors regarding the intersection of the Medicare Hospice Benefit and Part D Coverage.  The hospice community has also raised concerns about previous directives, and is alarmed by the fact that all communication from CMS has been directed to Part D plan sponsors, and not to hospice providers who will be impacted.

"Hospices absorb the costs for all care related to a patient's terminal condition, whether it be medication, DME, direct care from all members of the interdisciplinary team and anything necessary for the palliation of pain and management of symptoms.  We are not debating this in any way.  Since we were made aware of this issue, we have repeatedly asked for CMS to convene all of the impacted stakeholders – the hospice community, Part D sponsors, and pharmacies – to create a plan for ensuring that the proper entity is paying for the care of hospice patients.  Instead, for the sake of "administrative ease", CMS has moved forward with this guidance a truly careless and reckless manner," said Schumacher.

Jonathan Keyserling
NHPCO Senior Vice President, Health Policy
Ph: 703-837-3153

SOURCE National Hospice and Palliative Care Organization
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
2. Market Disruption Imminent as Hospitals and Physicians Aggressively Adopt Patient Portal Technology
3. Lack of Formulary Access Tops List of Limitations Primary Care Physicians Face With e-Prescribing Systems, Says New Research Report from SciMedica Group MR&C
4. Unique Glaucoma Test Through Eyelid DIATON Opens Doctors Eyes to Possibility of In-Office Glaucoma Test at Pri-Med East and American Academy of Family Physicians, AAFP
5. Update: 2013 List of Best Doctors in Dallas Features Texas Institute for Surgery Physicians
6. 2013 List of Best Doctors in Dallas Features Texas Institute for Surgery Physicians
7. Childhood Obesity Need Not Last a Lifetime, says Beverly Hills Physicians
8. Physicians Practice Wins Multiple Awards for Digital and Print Excellence
9. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
10. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
11. Parents May Have Even More Reason to Explore Weight Loss Surgery, suggests Beverly Hills Physicians
Post Your Comments:
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):